用失效模式和影响分析法规范药品供应链协同服务平台在门诊药房领药中的应用

陈燕红; 王井霞; 陶霞; 陈万生; 邬蓉

doi:10.3969/j.issn.1006-0111.2019.01.020

用失效模式和影响分析法规范药品供应链协同服务平台在门诊药房领药中的应用

doi: 10.3969/j.issn.1006-0111.2019.01.020

海军军医大学附属长征医院药材科, 上海 200003

基金项目: 临床合理用药监管流程的创新与服务探索（2016-YY-01-09）；上海市临床药学重点专科建设项目（2016-40044-002）；上海市卫生计生系统重要薄弱学科建设项目（2016ZB0303）

Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy

Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China

摘要: 目的强化门诊药房运用药品供应链协同服务平台领药的规范化管理，确保医院药品供应，合理降低药品库存积压，提升门诊药房领药管理能力。方法利用失效模式和影响分析（FMEA）法及时发现药品供应链协同服务平台中领药系统潜在的风险，并制定相应改进措施。结果通过对供应链服务平台领药流程的改进，使领药差错从137次下降为32次，风险降低比率达到76.64%，显著地降低了领药错误的风险。结论通过FMEA法，前瞻性地发现领药系统的漏洞和隐患，通过不断研究改进措施，切实提高药品供应链协同服务平台的领药功能，使门诊药房领药更加合理与准确。
- 失效模式和影响分析 /
- 门诊药房 /
- 供应链协同服务平台
Abstract: Objective To strengthen the system of drug supply chain collaborative service platform in drug supply, decrease drug inventory backlog, and improve the outpatient pharmacy management capacity in outpatient pharmacy. Methods Failure mode and effects analysis(FMEA) method was used to discover the potential risks in the drug supply chain collaborative service platform and formulate the corresponding improvement measures. Results The number of drug-receiving errors dropped from 137 times to 32 times and the risk reduction rate was 76.64% after improving the procurement process of the supply chain service platform, which significantly reduced the risk of contracting errors. Conclusion FMEA method could help to figure out the loopholes and hidden dangers of the pharmacy system, which made the outpatient pharmacy more reasonable and accurate by constantly improving the measures of the drug supply chain collaborative service platform.
- FMEA /
- outpatient pharmacy /
- supply chain collaborative service platform

[1]	陈莉华,黄齐慧,成明建,等.基于精益思想的医院领药业务流程再造[J].中国民族民间医药,2012,15(2):159-160.
[2]	李惠莹,云雄.供应链协同服务平台系统在医院药库中的应用[J].医药导报,2014,33(10):1398-1340.
[3]	沈烽,张健,杨传敏,等.我院药库物流信息化管理实践及体会[J].中国药房,2009,20(31):2429-2431.
[4]	周玲,缪丽燕.院内供应链药品采购模式对改善我院药品库存管理探讨[J].中国药房,2011,22(9):821.
[5]	马瑛,庞成森,王新鹏.完善医院药品供应链与优化库存结构的实践与体会[J].医药导报,2013,24(21):1969.
[6]	庞成森,董海燕,董亚琳.基于互联网的药品供应链协同平台在我院药库的应用[J].中国药师,2014,17(4):682-684.
[7]	SAE J. Potential failure mode and effects analysis in design (Design FMEA) potential failure mode and effects analysis in manufacturing and assembly processes (Process FMEA),and potential failure mode and effects analysis for machinery (Machinery FMEA)[S].2002.
[8]	SAE ARP5580.Recommended failure modes and effects analysis (FMEA) practices for non-automobile applications[S].2001.
[9]	BS EN60812:2006 Analysis techniques for system reliability,procedures for failure mode and effect analysis (FMEA)[S].2006.
[10]	于雁玲,武建康,范慧霞.失效模式后果分析在高危药品管理中的应用[J].中国药物与临床,2013,11:1503-1504.
[11]	ONODERA K.Effective techniques of FMEA at each life-cycle stage[A],Proceedings,Annual Reliability and Maintain-ability Symposium[C].IEEE,1997.
[12]	武志昂.试论药品风险管理和质量价值链[j].中国药物评价,2012,29(2):180-182.
[13]	ASHLEY L,ARMITAGE G.Failure mode and effects analysis:an empirical comparison of failure mode scoring procedures[J].J Patient Saf,2010,6(4):210-215.
[14]	宋相梅,曲建华,王莉梅,等.运用FMEA法规范住院药房麻醉药品及一类精神药品质量管理[J].中国药物评价,2017,34(2):153-156.
[15]	梁婉宁,赵育鹏,廖志斌.计算门诊药房二级库药品库存上下限的方法分析[J].中国医学创新,2017,14(10):140-143.
[16]	WU M,SIN A,NISHIOKA F,et al.Non-drug costa associated with outpatient infliximab administration in pediatric inflammatory bowel disease[J].Inflammatory Bowel Diseases,2013,19(7):1514-1517.
[17]	贾俊琴,宋沧桑,包金颖. PDCA循环在病区药品管理持续改进中的应用[J].中国药物评价,2016,33(4)::251-252.
[18]	宋菲,董迪,甄健存.风险管理在胰岛素及其类似物用药错误防范中的应用[J].药学实践杂志,2017,37(7):650-653.
[19]	PONTO T,ISMAIL N I,ABDUL MAJEED A B,et al.A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department,Hospital Tengku Ampuan Rahimah,Selangor,Malaysia[J].Methods Find Exp Clin Pharmacol,2010,32(6):427-432.
[20]	JAGER N G,ROSING H,SCHELLENS J H,et al. Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care[J].Breast Cancer Res Treat,2014,143(3):477-483.
[21]	KUO G M,TOUCHETTE D R,MARINAC J S.Drug errors and related interventions reported by United States clinical pharmacists:the American College of Clinical Pharmacy practice-based research network medication error detection,amelioration and prevention study[J].Pharmacotherapy,2013,33(3):253-265.
[22]	BAO L,WANG Y,SHANG T,et al.A novel clinical pharmacy management system in improving the rational drug use in department of general surgery[J].Indian J Pharm Sci,2013,75(1):11-15.
[23]	YEH M L,CHANG Y J,YEH S J,et al.Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants[J].Computer Methods and Programs in Biomedicine,2014,113(1):15-22.

[1]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[2]	黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉. 耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 445-450. doi: 10.12206/j.issn.2097-2024.202309059
[3]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[4]	史生辉, 石飞, 雷琼, 王亚峰, 吴雪花. 青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
[5]	刘依秦, 王超群, 邱娇娜. 胆宁片预处理在糖尿病患者结肠镜检查前的应用效果分析 . 药学实践与服务, 2024, 42(9): 407-410. doi: 10.12206/j.issn.2097-2024.202407037
[6]	宋红卫, 王燕, 方铭, 马云鹏, 钟超, 徐一新, 徐峰, 周婷. 2021−2023年我院药品不良反应的特点分析 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202404041
[7]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[8]	崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺. 临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050
[9]	尹小娟, 台力丽, 肖俊峰, 季波. 铜绿假单胞菌合并按蚊伊丽莎白菌肺部感染的病例分析 . 药学实践与服务, 2024, 42(5): 223-226. doi: 10.12206/j.issn.2097-2024.202310042
[10]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗的新观点和未来展望 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[11]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[12]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[13]	张修平, 田家盛, 王道鑫, 李佳鑫, 王品, 缪朝玉. MT-1207对血糖、血脂和动脉粥样硬化的作用 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202306011
[14]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
[15]	瞿文君, 白若楠, 崔力, 周琰. 基于联合库存的公立医院多院区药品采购模式分析 . 药学实践与服务, 2024, 42(7): 315-318. doi: 10.12206/j.issn.2097-2024.202401002

点击查看大图

计量

文章访问数: 3275
HTML全文浏览量: 397
PDF下载量: 447
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

用失效模式和影响分析法规范药品供应链协同服务平台在门诊药房领药中的应用

doi: 10.3969/j.issn.1006-0111.2019.01.020

Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy

计量

用失效模式和影响分析法规范药品供应链协同服务平台在门诊药房领药中的应用

doi: 10.3969/j.issn.1006-0111.2019.01.020

海军军医大学附属长征医院药材科, 上海 200003

English Abstract

Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy

Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China

全文HTML

目录

留言板

用失效模式和影响分析法规范药品供应链协同服务平台在门诊药房领药中的应用

doi: 10.3969/j.issn.1006-0111.2019.01.020

Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy

计量

出版历程

用失效模式和影响分析法规范药品供应链协同服务平台在门诊药房领药中的应用

doi: 10.3969/j.issn.1006-0111.2019.01.020

海军军医大学附属长征医院药材科, 上海 200003

English Abstract

Application of FMEA regulated drug supply chain collaborative service platform for drug-receiving in outpatient pharmacy

Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China

全文HTML

目录